NCT06448403 · RECRUITING
Multimodal Assesment of Alzheimer Patients
This study is collecting brain scans, EEG recordings, sleep studies, blood samples, stool samples, and cognitive test results from people with MCI or Alzheimer's disease — plus healthy controls — to look for early warning signs of Alzheimer's. It is an observational study, not a treatment trial, so no phase applies. No intervention is being tested; researchers are building a richer picture of how the disease develops.
You may qualify if
- MCI and AD according to relevant ICD-criterias.
- Control cohort is age and gender matched with other cohorts.
You're excluded if
- Uneligibility for any of the planned neuroimagery devices (MRI, EEG)
- AD diagnosis before the age of 65 (Early-onset AD).
- Brain tumor
- Traumtic head injury
- Earlier neurosurgery
- Other neyrodegenerative diseases (i.e Parkinson and ALS)
- Diseases related to inflammation and auto-immunity (i.e MS)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-08-07